NFL has been proposed as a potential biomarker for various neurodegenerative diseases, such as AD, PD, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and traumatic brain injury [13,14,15]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.